Dissolution tests are conducted to check a time it takes for a active partial in a drug to release into a body, and assistance envision how a drug performs inside a body.
According to a Food and Drug Administration (FDA), a remember of Dr. Reddy’s metoprolol succinate extended recover tablets, USP 25 mg. 100-count bottle, is a Class II recall. This means use of or bearing to a removed products might means proxy or medically reversible inauspicious health consequences.
Metoprolol succinate extended recover is a reduction costly general form of AstraZeneca’s Toprol XL.
Learn More About High Blood Pressure Medications »
This remember comes on a heels of Wockhardt Ltd.’s remember of 109,744 bottles of a same drug final month for a same reason. Both companies’ recalls were personal by a FDA as Class II.
In March, Dr. Reddy’s removed about 58,656 bottles of a heartburn drug lansoprazole in a U.S. since of a microbial contamination.
Dr. Reddy’s began to willingly remember metoprolol succinate on May 23, 2014; a remember was posted on a FDA website on Jun 19, 2014.
An FDA orator told Healthline, “The new Wockhardt and Dr. Reddy’s metoprolol succinate recalls are eccentric removed events that a companies are willingly addressing. These don’t simulate a whole product lines, though a specific lots identified in any remember event. These recalls are a outcome of slight tests that code and general companies perform as partial of their peculiarity management.”
The FDA orator added, “This is a Class II recall, that means that it is during a pharmacy level, so patients can still take a product; however, if they are endangered they can pronounce with a alloy for recommendation and option.”
Healthline contacted a Dr. Reddy’s orator in India, who pronounced a association has put a visual movement devise in place.
Learn About High Blood Pressure»